Steven N Kalkanis, MD

Member of the Henry Ford Cancer Institute

Titles:

• CEO, Henry Ford Medical Group
• Senior Vice President and Chief Academic Officer
• Professor & Chairman, Department of Neurosurgery
• Mark L. Rosenblum Endowed Chair in Neurosurgery
• Medical Director, Henry Ford Cancer Institute
• Co-Director, Henry Ford Neuroscience Institute

As a member of the Hermelin Brain Tumor Center team, I specialize in the treatment of all brain tumors including clinical trials; intracranial neurosurgery, spinal cord tumors, adult cervical and lumbar spine disease, general neurosurgery and stereotactic neurosurgery.

Research Interests

• Brain Cancer Research
• Clinical trials and outcome studies for brain tumor patients
• Targeted cell-based therapy for the treatment of malignant gliomas
• Viral gene therapy and stem cell delivery for novel brain cancer therapies
• Survival-associated genetic studies for the development of personalized medicine protocols for brain tumor patients

Awards and Honors

• Past Chair, AANS/CNS Section on Tumors
• Director, American Board of Neurological Surgery
• President-elect, Congress of Neurological Surgeons  
• National Executive Committee member of both the Congress of Neurological Surgeons and the Joint Tumor Section Chair
• National Tumor Section Guidelines Committee
• Lead Author of the national guidelines for the treatment of brain metastases
• President, Michigan Association of Neurological Surgeons
• Editor, Neurosurgery journal
• Voted one of Michigan's Top Docs by Hour Magazine, 2008-2012
• Selected as the national first-place research award recipient by both the American College of Surgeons and the Congress of Neurological Surgeons
• Director of the American Board of Neurological Surgery (ABNS)
• President-elect, Congress of Neurological Surgeons